$LLY (-2,36 %)
$NOVO B (+0,8 %) Eli Lilly shares fall 1.5% after HSBC downgrades the pharmaceutical company's shares twice from "buy" to "reduce".
Rival Novo Nordisk launches weight-loss drug Wegovy in Thailand, ahead of Lilly's Zepbound. Source: https://de.tradingview.com/news/reuters.com,2025:newsml_L8N3R61LI:0/
Stay tuned, next week there will be new figures from Novo. From the low on April 17 Novo has already recovered +10% away. Let's see if and how often the support around €51 will be tested🙄
update April 30: Novo was able to increase to +15% from the low by the end of the month. Positive news about cooperations allowed the share to "breathe a sigh of relief". Let's see if we still see the 62€ before the earnings🙄
